IB-001

N/A

Report date: 2024/10/23 11:10:21

Base Information

Drug NameIB-001

Drug Alias NameIB-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionBAG family molecular chaperone regulator 3 inhibitors

TargetsBAG family molecular chaperone regulator 3

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIntrepida Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A